Safety, Tolerability and Pharmacokinetics of Oral BIBP 5371 CL in Healthy Male and Female Volunteers

NCT02256709 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBP 5371 CL tablet
DRUG: BIBP 5371 CL solution
OTHER: High fat, high caloric breakfast
DRUG: Placebo tablet
DRUG: BIBP 5371 CL tablet high dose
DRUG: Placebo drinking solution
DRUG: BIBP 5371 CL tablet low dose

Sponsor

Boehringer Ingelheim